Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
101.8 ILa | 0.00% | 0.00% | -19.97% |
2023 | Nextgen Biomed Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Nextgen Biomed Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.18M 10.07B |
---|---|---|---|---|---|
Net income 2021 | -2M -741M | Net income 2022 | -8M -2.96B | EV / Sales 2021 | - |
Net cash position 2021 | 11.96M 4.43B | Net cash position 2022 | 5.24M 1.94B | EV / Sales 2022 | - |
P/E ratio 2021 |
-21.7
x | P/E ratio 2022 |
-3.17
x | Employees | 15 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 92.06% |
3 months | +0.39% | ||
6 months | -23.92% | ||
Current year | -19.97% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-11-19 | |
Dalia Mulakandov
DFI | Director of Finance/CFO | 39 | 23-01-16 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 00-08-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Grossman
BRD | Director/Board Member | 49 | 22-06-11 |
Yaacov Amidror
CHM | Chairman | 76 | 21-01-06 |
Alon Pinkas
BRD | Director/Board Member | 62 | 22-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 101.8 | 0.00% | 0 |
24-06-09 | 101.8 | 0.00% | 0 |
24-06-06 | 101.8 | 0.00% | 0 |
24-06-05 | 101.8 | 0.00% | 0 |
24-06-04 | 101.8 | 0.00% | 0 |
Delayed Quote TEL AVIV STOCK EXCHANGE, June 10, 2024 at 10:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.97% | 2.22M | |
+8.99% | 27.32B | |
-42.44% | 2.59B | |
+25.56% | 2.45B | |
-21.58% | 2.35B | |
+8.13% | 2.26B | |
+21.11% | 1.85B | |
-11.44% | 1.87B | |
+29.15% | 1.35B | |
+32.97% | 1.33B |
- Stock Market
- Equities
- NXGN Stock